Analyst Andrew Douglas from Jefferies maintained a Buy rating on Bodycote and decreased the price target to p920.00 from p925.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Andrew Douglas has given his Buy rating due to a combination of factors, including Bodycote’s preliminary FY25 results modestly surpassing profit and earnings expectations and an even stronger finish to the year. He also highlights the company’s solid balance sheet, better-than-expected net debt position, and the announcement of an £80m share repurchase program, which together underscore strong cash generation and capital allocation discipline.
Douglas further notes that management has navigated a difficult FY25 effectively while advancing key strategic initiatives, with the ‘Optimise’ programme already delivering benefits and ‘Perform’ and ‘Grow’ poised to drive performance in FY26 and beyond. Although demand conditions across end markets in FY26 will be mixed, he expects healthy growth in a significant portion of the portfolio, improving earnings quality and largely unchanged or slightly higher consensus forecasts, which he believes should support a constructive market reaction and justifies maintaining the Buy recommendation.
Douglas covers the Industrials sector, focusing on stocks such as Avon Technologies, Bodycote, and Senior plc. According to TipRanks, Douglas has an average return of 5.6% and a 57.89% success rate on recommended stocks.

